Clinical Trials Directory

Trials / Completed

CompletedNCT02322138

Gastrointestinal Tolerance of Infant Formula

Gastrointestinal Tolerance of Formula Supplemented With Prebiotics

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
131 (actual)
Sponsor
Abbott Nutrition · Industry
Sex
All
Age
8 Days
Healthy volunteers
Accepted

Summary

The study objective is to evaluate the gastrointestinal tolerance of infant formula supplemented with prebiotics.

Conditions

Interventions

TypeNameDescription
OTHERExperimental 1 Infant FormulaReady to feed infant formula to be fed ad-libitum
OTHERExperimental 2 Infant FormulaReady to feed infant formula to be fed ad-libitum
OTHERReference GroupBreast fed ad libitum

Timeline

Start date
2015-01-01
Primary completion
2015-06-01
Completion
2015-06-01
First posted
2014-12-23
Last updated
2015-07-23

Locations

10 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02322138. Inclusion in this directory is not an endorsement.

Gastrointestinal Tolerance of Infant Formula (NCT02322138) · Clinical Trials Directory